Tools & Calculators
Sector: Pharmaceuticals & Biotechnology
|Large Cap
AstraZeneca Pharma India Ltd.
₹8,807
Invest in ASTRAZEN with up to 2.50x margin.
Trade with MTF₹8807.00
₹8944.50
₹6620.10
₹10691.00
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 611.57 | 559.09 | 526.31 | 480.48 | 440.29 |
| Operating Expense | 566.74 | 483.91 | 445.20 | 394.11 | 363.47 |
| Operating Profit | 44.83 | 75.18 | 81.11 | 86.37 | 76.99 |
| Depreciation | 3.84 | 2.57 | 16.57 | 17.69 | 9.07 |
| Interest | 1.06 | 0.67 | 0.72 | 0.68 | 0.33 |
| Tax | 13.95 | 18.60 | 18.87 | 20.22 | 11.17 |
| Net Profit | 32.59 | 54.22 | 55.83 | 58.25 | 30.85 |
₹8807.00
↗ Bullish Moving Average
10
↘ Bearish Moving Average
6
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 75 | 75 | 75 | 75 | 75 | 75 |
| FII | 2.9 | 2.9 | 2.9 | 3 | 2.7 | 2.7 |
| DII | 5.1 | 5.2 | 4.6 | 4.6 | 5.3 | 5.6 |
| Public | 17 | 16.8 | 17.4 | 17.4 | 17 | 16.7 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 2.69 K | 3.84 K | 70.02% |
| Week | 1.74 K | 3.39 K | 51.32% |
| 1 Month | 3.28 K | 7.49 K | 43.82% |
| 6 Month | 6.17 K | 13.37 K | 46.17% |
Companies with no Debt
Benjamin Graham Value Screen
Consistent high performing stocks over Five Years
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over 1 Year
Expensive Performers (DVM)
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Increasing Revenue every Quarter for the past 8 Quarters
Increasing Revenue every Quarter for the past 4 Quarters
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
RSI indicating price strength
Volume Shockers
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 18 Jul, 2025 | 32 | FINAL | 18 Jul, 2025 | Equity Share |
| 05 Jul, 2024 | 24 | FINAL | 05 Jul, 2024 | Equity Share |
| 14 Jul, 2023 | 16 | FINAL | 14 Jul, 2023 | Equity Share |
| 07 Jul, 2022 | 8 | FINAL | 08 Jul, 2022 | Equity Share |
| 18 Aug, 2021 | 2 | INTERIM | 20 Aug, 2021 | Equity Share |
| 20 Aug, 2020 | 2 | INTERIM | 21 Aug, 2020 | Equity Share |
| 20 Aug, 2019 | 1 | INTERIM | 21 Aug, 2019 | Equity Share |
| 09 Jul, 2012 | 3.5 | FINAL | Equity Share | |
| 07 Jul, 2011 | 10 | FINAL | Equity Share | |
| 06 May, 2010 | 10 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹696.90 | ₹1,431.80 | ₹2,045 | ₹162 | ₹1,803 | ₹1,014.60 |
| % Change | 2.20% | -0.42% | 1.02% | 0.92% | -1.03% | -0.43% |
| Revenue TTM (₹ Cr) | ₹1,996.59 | ₹8,850.08 | ₹13,914.08 | ₹8,871.37 | ₹6,112.77 | ₹6,721.63 |
| Net Profit TTM (₹ Cr) | ₹484.66 | ₹869.92 | ₹1,779.35 | ₹-163.61 | ₹847.18 | ₹843.32 |
| PE TTM | 80.70 | 31.30 | 47.50 | -131.70 | 35.10 | 65.10 |
| 1 Year Return | 22.17 | 44.17 | -12.08 | -22.44 | 18.09 | 95.04 |
| ROCE | 26.88 | 20.80 | 13.27 | 6.40 | 11.43 | 11.82 |
Alkem Laboratories Ltd.
₹ 5487.00
+1.76%
Biocon Ltd.
₹ 388.00
+1.05%
Divi's Laboratories Ltd.
₹ 6258.50
-0.52%
Ajanta Pharma Ltd.
₹ 2975.00
+1.21%
Zydus Lifesciences Ltd.
₹ 905.30
-
Glenmark Pharmaceuticals Ltd.
₹ 2033.00
-0.50%
Wockhardt Ltd.
₹ 1370.00
-0.84%
Aurobindo Pharma Ltd.
₹ 1148.70
-0.87%
Sun Pharmaceutical Industries Ltd.
₹ 1732.00
+0.44%
Ipca Laboratories Ltd.
₹ 1469.70
+1.37%
J B Chemicals & Pharmaceuticals Ltd.
₹ 2051.00
+2.53%
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2635.30
+1.48%
Pfizer Ltd.
₹ 5066.60
+2.74%
Abbott India Ltd.
₹ 26425.00
+0.49%
Torrent Pharmaceuticals Ltd.
₹ 4318.50
+1.81%
Lupin Ltd.
₹ 2241.00
+0.97%
Dr. Reddy's Laboratories Ltd.
₹ 1305.10
+1.93%
Cipla Ltd.
₹ 1327.00
-1.05%
By signing up I certify terms, conditions & privacy policy